Clinical Trials Directory

Trials / Unknown

UnknownNCT01438736

Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern?

A Randomized Study to Evaluate the Predictive Impact of Using Cerazette Progestin Only Pill Before Nexplanon Insertion Regarding Bleeding Pattern

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
VL-Medi Oy · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to examine how well three months preceding use of Cerazette progestin only pill predicts the bleeding pattern during following Nexplanon implant use.

Conditions

Interventions

TypeNameDescription
DRUGDesogestrel 75 micrograms POP (Cerazette), Etonogestrel 68 mg implant (Nexplanon)Desogestrel 75 micrograms POP daily for 3 monts, followed by etonogestrel 68 mg subdermal implant for following 6 months
DRUGEtonogestrel 68 mg subdermal implantEtonogestrel 68 mg subdermal implant for 6 months

Timeline

Start date
2011-09-01
Primary completion
2012-11-01
First posted
2011-09-22
Last updated
2011-09-22

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT01438736. Inclusion in this directory is not an endorsement.

Is Cerazette Use Before Nexplanon Insertion Predictive for Bleeding Pattern? (NCT01438736) · Clinical Trials Directory